BBNX
Beta Bionics, Inc.
21.90$
+2.1%
vs. previous close
Closing price · As of: Sep 18, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | |
| – | 47.4% | 44.9% | 44.6% | |
| 100.0% | 52.6% | 55.1% | 55.4% | |
| 17,557.5% | 149.6% | 40.2% | 34.7% | |
| 13,781.0% | 101.9% | 27.4% | 30.9% | |
| 36,884.4% | 351.5% | 124.6% | 126.9% | |
| -36,784.4% | -298.9% | -69.5% | -71.5% | |
| 7.8% | 0.6% | – | – | |
| -36,173.7% | -367.6% | -84.1% | -73.0% | |
| – | – | – | 0.0% | |
| -36,173.7% | -367.6% | -84.1% | -73.0% | |
| -35,418.4% | -357.4% | -82.3% | -70.1% |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.